logo

For the Inventor, By the Inventor

Wilmington, DE, United States of America

Jenrin Discovery, Inc.


USPTO Granted Patents = 27

% Expired Patents = 51.9



Forward Citations = 174

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Robert J Chorvat (27 out of 48 patents)

silverMedal John Francis McElroy (27 out of 33 patents)

bronzeMedal Parthasarathi Rajagopalan (2 out of 13 patents)

4.  Rajagopalan Parthasarathi (2 out of 2 patents)

5.  David Nugiel (1 out of 7 patents)

6.  John Mcelroy (0 patent)

7.  John F Mcelroy (0 patent)

8.  John Mcelroy (0 patent)

9.  John Mcelroy (0 patent)

10.  John F Mcelroy (0 patent)


Core Competencies:
Cannabinoid Receptor Antagonists
Inverse Agonists
Metabolic Disorders
Obesity
Diabetes
MAO-B Inhibitors
Anti-Malarial Agents
Purine Compounds
N-Phenyl-Pyrazolin Amides
Picolinamides
N-Benzyl-Amine Compounds

27 patents:

1. 11179370 - Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers (2021-11-23),
2. 10617673 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2020-04-14),
3. 9987253 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2018-06-05),
4. 9517228 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2016-12-13),
5. 9133127 - Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers (2015-09-15),
6. 8853252 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2014-10-07),
7. 8716265 - 4-quinolinemethanols as anti-malarial agents (2014-05-06),
8. 8680131 - Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers (2014-03-25),
9. 8648072 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2014-02-11),
10. 8580768 - Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2013-11-12),
11. 8541475 - MAO-B inhibitors useful for treating obesity (2013-09-24),
12. 8334282 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2012-12-18),
13. 8252791 - Purine compounds as cannabinoid receptor blockers (2012-08-28),
14. 8236821 - Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity (2012-08-07),
15. 8217038 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2012-07-10),
Company Overview
Jenrin Discovery, Inc. is a biotechnology company based in Wilmington, Delaware, specializing in the development of innovative therapeutic solutions. The organization focuses on advancing drug discovery and development processes, particularly in the fields of oncology and rare diseases. By leveraging cutting-edge technologies and a robust research framework, Jenrin aims to address unmet medical needs and improve patient outcomes through targeted therapies and novel treatment modalities.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

27 Patents

#171 in Wilmington, DE

#206 in Delaware

#12,410 in US

#23,984 in the World

Wilmington, DE (US)
Wilmington, DE, United States of America

Jenrin Discovery, Inc.

Forward Citations = 174

5 inventors:

goldMedal Robert J Chorvat (27 out of 48 patents)

silverMedal John Francis McElroy (27 out of 33 patents)

bronzeMedal Parthasarathi Rajagopalan (2 out of 13 patents)

4.  Rajagopalan Parthasarathi (2 out of 2 patents)

5.  David Nugiel (1 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Jenrin Discovery, Inc.. Retrieved from https://idiyas.com/company/jenrin-discovery

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…